Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDFaeth Therapeuti Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q2 2026 | 5 | -$4.29 | -$1.51 | -$2.64 |
| Q3 2026 | 3 | -$0.86 | -$0.68 | -$0.78 |
| Q4 2026 | 3 | -$0.90 | -$0.68 | -$0.77 |
| Q1 2027 | 1 | -$0.74 | -$0.74 | -$0.74 |
| Q2 2027 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q3 2027 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q4 2027 | 1 | -$0.79 | -$0.79 | -$0.79 |
| Q1 2028 | 2 | -$0.74 | -$0.74 | -$0.74 |
| Q2 2028 | 2 | -$0.75 | -$0.75 | -$0.75 |
| Q3 2028 | 2 | -$0.75 | -$0.75 | -$0.75 |
| Q4 2028 | 2 | -$0.76 | -$0.76 | -$0.76 |
Faeth Therapeuti Earnings Date And Information
Faeth Therapeuti last posted its earnings results on Tuesday, August 4th, 2026. The company reported $-2.84 earnings per share for the quarter, missing analysts' consensus estimates of $-2.64 by $0.2. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Faeth Therapeuti has generated $-17 earnings per share over the last year ($-16.72 diluted earnings per share) and currently has a price-to-earnings ratio of -0.13. Faeth Therapeuti has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Faeth Therapeuti Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/04/2026 | Q2 2026 | -$2.64 | -$2.84 | -0.2 | $0 | $0 |
| 05/15/2026 | Q1 2026 | -$0.62 | -$131.45 | -130.83 | $0 | $0 |
| 03/30/2026 | Q4 2025 | -$4.81 | -$3.74 | 1.07 | N/A | $0 |
| 11/14/2025 | Q3 2025 | -$4.11 | -$3.62 | 0.49 | N/A | $-4,851,000 |
| 08/05/2025 | Q2 2025 | -$6.20 | -$3.91 | 2.29 | N/A | $0 |
| 05/06/2025 | Q1 2025 | -$4.20 | -$5.45 | -1.25 | N/A | $0 |
| 03/28/2025 | Q4 2024 | -$5.40 | -$6.18 | -0.78 | N/A | $0 |
| 11/14/2024 | Q3 2024 | -$6.20 | -$5.77 | 0.43 | N/A | $0 |
| 08/06/2024 | Q2 2024 | -$5.00 | -$5.69 | -0.69 | N/A | $0 |
| 05/09/2024 | Q1 2024 | -$5.80 | -$6.38 | -0.58 | N/A | $0 |
| 02/29/2024 | Q4 2023 | N/A | -$5.92 | N/A | N/A | $0 |
| 11/07/2023 | Q3 2023 | -$5.60 | -$5.58 | 0.02 | N/A | $0 |
| 08/03/2023 | Q2 2023 | -$6.40 | -$6.15 | 0.25 | N/A | $0 |
| 05/09/2023 | Q1 2023 | -$0.36 | -$6.59 | -6.23 | N/A | $0 |
| 05/01/2023 | Q4 2022 | N/A | -$7.96 | N/A | N/A | $0 |
| 11/08/2022 | Q3 2022 | -$0.37 | -$8.73 | -8.36 | N/A | $0 |
| 08/09/2022 | Q2 2022 | -$8.00 | -$6.86 | 1.14 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$7.00 | -$8.10 | -1.1 | N/A | $0 |
| 03/15/2022 | Q4 2021 | N/A | -$6.12 | N/A | N/A | $0 |
| 11/10/2021 | Q3 2021 | N/A | -$6.33 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Faeth Therapeuti Earnings: FAQ's
The conference call for Faeth Therapeuti's latest earnings report can be listened to online.
The conference call transcript for Faeth Therapeuti's latest earnings report can be read online.
Faeth Therapeuti (:FTH) has a recorded net income of $-21,085,000.Faeth Therapeuti has generated $-16.72 earnings per share over the last four quarters.
Faeth Therapeuti (:FTH) has a price-to-earnings ratio of -0.13 and price/earnings-to-growth ratio is 0.